GLABF
Price
$0.32
Change
+$0.06 (+23.08%)
Updated
Oct 2 closing price
Capitalization
24.61M
Intraday Buy/Sell Signals
VKTX
Price
$34.67
Change
+$1.62 (+4.90%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
3.72B
6 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

GLABF vs VKTX

Header iconGLABF vs VKTX Comparison
Open Charts GLABF vs VKTXBanner chart's image
GEMINA LABORATORIES
Price$0.32
Change+$0.06 (+23.08%)
Volume$115
Capitalization24.61M
Viking Therapeutics
Price$34.67
Change+$1.62 (+4.90%)
Volume$8.91K
Capitalization3.72B
GLABF vs VKTX Comparison Chart in %
View a ticker or compare two or three
VS
GLABF vs. VKTX commentary
Oct 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLABF is a Hold and VKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 16, 2025
Stock price -- (GLABF: $0.32 vs. VKTX: $33.05)
Brand notoriety: GLABF and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLABF: 3% vs. VKTX: 42%
Market capitalization -- GLABF: $24.61M vs. VKTX: $3.72B
GLABF [@Biotechnology] is valued at $24.61M. VKTX’s [@Biotechnology] market capitalization is $3.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLABF’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • GLABF’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than GLABF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLABF’s TA Score shows that 1 TA indicator(s) are bullish while VKTX’s TA Score has 5 bullish TA indicator(s).

  • GLABF’s TA Score: 1 bullish, 5 bearish.
  • VKTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VKTX is a better buy in the short-term than GLABF.

Price Growth

GLABF (@Biotechnology) experienced а 0.00% price change this week, while VKTX (@Biotechnology) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.72B) has a higher market cap than GLABF($24.6M). VKTX YTD gains are higher at: -17.868 vs. GLABF (-41.347). GLABF has higher annual earnings (EBITDA): -3.24M vs. VKTX (-212.42M). VKTX has more cash in the bank: 808M vs. GLABF (-167). GLABF has less debt than VKTX: GLABF (241K) vs VKTX (878K). GLABF has higher revenues than VKTX: GLABF (10.9K) vs VKTX (0).
GLABFVKTXGLABF / VKTX
Capitalization24.6M3.72B1%
EBITDA-3.24M-212.42M2%
Gain YTD-41.347-17.868231%
P/E RatioN/AN/A-
Revenue10.9K0-
Total Cash-167808M-0%
Total Debt241K878K27%
FUNDAMENTALS RATINGS
VKTX: Fundamental Ratings
VKTX
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
7

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLABFVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
38%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 30 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GLABF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AALRX29.150.36
+1.25%
American Beacon Large Cap Value R6
MFLDX26.26N/A
N/A
Cromwell Long Short Institutional
TASVX17.89N/A
N/A
PGIM Quant Solutions Small-Cap Val Z
VEUPX189.98N/A
N/A
Vanguard European Stock Instl Plus
KLGNX53.29-0.41
-0.76%
NYLI WMC Growth Investor Class

GLABF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLABF
1D Price
Change %
GLABF100%
N/A
ELVAF - GLABF
36%
Loosely correlated
N/A
QCLS - GLABF
29%
Poorly correlated
+12.08%
IDRSF - GLABF
23%
Poorly correlated
N/A
VYGR - GLABF
22%
Poorly correlated
+1.94%
ENTO - GLABF
8%
Poorly correlated
-4.09%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-2.54%
NEVPF - VKTX
45%
Loosely correlated
N/A
SYRE - VKTX
42%
Loosely correlated
+11.02%
GPCR - VKTX
41%
Loosely correlated
+0.03%
TERN - VKTX
39%
Loosely correlated
-1.40%
BCRX - VKTX
38%
Loosely correlated
-8.81%
More